HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sequential morphologic changes during methapyrilene-induced hepatocellular carcinogenesis in rats.

Abstract
The pathogenesis of hepatocellular tumors induced in F344 rats by the antihistaminic methapyrilene was investigated by light and electron microscopy in a serial sacrifice study. Eosinophilic foci of altered hepatocytes were found in portal areas after 1 week of treatment, the eosinophilia being caused by proliferation of mitochondria. Eosinophilic neoplastic nodules developed from such lesions after 16 weeks of treatment. Hepatocellular carcinomas developed after 26 weeks of treatment. Mitochondrial proliferation, which had been found as a marker for hepatocytes altered by this compound at 1 week of treatment, was still present in the hepatocellular carcinomas, which therefore met the morphologic criteria of oncocytomas.
AuthorsH M Reznik-Schüller, M Gregg
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 71 Issue 5 Pg. 1021-31 (Nov 1983) ISSN: 0027-8874 [Print] United States
PMID6580478 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Aminopyridines
  • Methapyrilene
Topics
  • Aminopyridines (toxicity)
  • Animals
  • Eosinophilia (chemically induced)
  • Liver (drug effects, ultrastructure)
  • Liver Neoplasms, Experimental (chemically induced, pathology, ultrastructure)
  • Male
  • Methapyrilene (toxicity)
  • Mitochondria (ultrastructure)
  • Precancerous Conditions (chemically induced, ultrastructure)
  • Rats
  • Rats, Inbred F344
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: